NCT02110251

Brief Summary

Patients with peripheral arterial disease with symptoms of critical ischemia or reduced tissue loss have a very high mortality and morbidity rate. So far, treatment strategies focused on the preservation of life and limb by an open surgical or endovascular revascularization, together with cardiovascular risk management and pain relief. Important modifiable factors related to mortality and morbidity are not covered in the current national and international guidelines. This study investigates the effects on mobility, mortality and quality of life with supplementation of the standard treatment of critical limb ischemia with supervised exercise therapy. Also a reduction of cardiovascular risk by intensive risk factor management and lifestyle coaching will be taken in to account. The supervised exercise therapy will take place under the supervision of a trained physiotherapist.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2011

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

April 1, 2014

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 10, 2014

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

July 25, 2019

Status Verified

July 1, 2019

Enrollment Period

2.9 years

First QC Date

April 1, 2014

Last Update Submit

July 23, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mobility

    Pain free walking distance WIQ ALDS

    2 years

Secondary Outcomes (2)

  • Quality of life

    2 years

  • Mortality

    2 years

Study Arms (2)

Supervised exercise therapy

EXPERIMENTAL

Adequacy of initial therapy, Investigation degree of confusion and dementia, Preoperative preparation, Life-style coaching, Supervised Exercise therapy.

Behavioral: Supervised Exercise Therapy

Walking advice

NO INTERVENTION

Standard care and a oral walking advice.

Interventions

Supervised exercise therapy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with peripheral arterial disease Rutherford stage 4 and 5, where it is possible to improve the vascularization of the affected leg with the help of an endovascular and / or open surgical vascular intervention.
  • Patients with both legs are affected, but the most severe leg does not exceed stage 5.

You may not qualify if:

  • Severe cardiopulmonary comorbidity (NYHA 4) and previous amputations of lower leg or thigh.
  • Patients with limited amputation of the toes can participate.
  • Insufficient understanding of the Dutch language.
  • No physiotherapy insurance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Catharina Ziekenhuis

Eindhoven, North Brabant, 5623 EJ, Netherlands

Location

Medisch Centrum Alkmaar

Alkmaar, 1815 JD, Netherlands

Location

MeSH Terms

Conditions

Peripheral Arterial Disease

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular Diseases

Study Officials

  • Joep Teijink, prof. dr.

    Catharina Ziekenhuis Eindhoven

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
prof. dr.

Study Record Dates

First Submitted

April 1, 2014

First Posted

April 10, 2014

Study Start

September 1, 2011

Primary Completion

August 1, 2014

Study Completion

August 1, 2014

Last Updated

July 25, 2019

Record last verified: 2019-07

Locations